Dimeric protein with triple mutations
US11180572B2 · kind B2 · utility
9Cited by
10References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 2013 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Feb 13, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to dimeric proteins comprising amino acids at three different positions which are different from those present in a human IgG1. Six of said dimeric proteins are capable of forming a hexameric structure in solution.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.